204 related articles for article (PubMed ID: 35977725)
21. A "masked" pleomorphic xanthoastrocytoma.
Franca RA; Ugga L; Della Monica R; Corvino S
Pathol Res Pract; 2023 Aug; 248():154698. PubMed ID: 37499517
[TBL] [Abstract][Full Text] [Related]
22. Clinical-pathological study of 28 glial and mixed neuronal-glial tumors diagnosed within the first year of life.
Buccoliero AM; Caporalini C; Moscardi S; Spacca B; Scagnet M; Castiglione F; Sardi I; Giunti L; Genitori L
Clin Neuropathol; 2022; 41(1):25-34. PubMed ID: 34622774
[TBL] [Abstract][Full Text] [Related]
23. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
24. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
[TBL] [Abstract][Full Text] [Related]
25. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
[TBL] [Abstract][Full Text] [Related]
26. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A
Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258
[TBL] [Abstract][Full Text] [Related]
27. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.
Schäfer S; Behling F; Skardelly M; Koch M; Ott I; Paulsen F; Tabatabai G; Schittenhelm J
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):207-223. PubMed ID: 29053887
[TBL] [Abstract][Full Text] [Related]
28. Integrated molecular characterization of IDH-mutant glioblastomas.
Korshunov A; Casalini B; Chavez L; Hielscher T; Sill M; Ryzhova M; Sharma T; Schrimpf D; Stichel D; Capper D; Reuss DE; Sturm D; Absalyamova O; Golanov A; Lambo S; Bewerunge-Hudler M; Lichter P; Herold-Mende C; Wick W; Pfister SM; Kool M; Jones DTW; von Deimling A; Sahm F
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):108-118. PubMed ID: 30326163
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.
Ebrahimi A; Korshunov A; Reifenberger G; Capper D; Felsberg J; Trisolini E; Pollo B; Calatozzolo C; Prinz M; Staszewski O; Schweizer L; Schittenhelm J; Harter PN; Paulus W; Thomas C; Kohlhof-Meinecke P; Seiz-Rosenhagen M; Milde T; Casalini BM; Suwala A; Wefers AK; Reinhardt A; Sievers P; Kramm CM; Etminam N; Unterberg A; Wick W; Herold-Mende C; Sturm D; Pfister SM; Sill M; Jones DTW; Schrimpf D; Reuss DE; Aldape K; Abdullaev Z; Sahm F; von Deimling A; Stichel D
Acta Neuropathol Commun; 2022 Jan; 10(1):5. PubMed ID: 35012690
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA519d and microRNA4758 can identify gangliogliomas from dysembryoplastic neuroepithelial tumours and astrocytomas.
Bongaarts A; Prabowo AS; Arena A; Anink JJ; Reinten RJ; Jansen FE; Spliet WGM; Thom M; Coras R; Blümcke I; Kotulska K; Jozwiak S; Grajkowska W; Söylemezoğlu F; Pimentel J; Schouten-van Meeteren AYN; Mills JD; Iyer AM; van Vliet EA; Mühlebner A; Aronica E
Oncotarget; 2018 Jun; 9(46):28103-28115. PubMed ID: 29963264
[TBL] [Abstract][Full Text] [Related]
31. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma.
Galanis E; Wen PY; de Groot JF; Weller M
Hematol Oncol Clin North Am; 2022 Feb; 36(1):113-132. PubMed ID: 34756799
[TBL] [Abstract][Full Text] [Related]
32. Malignant Transformation of Pediatric Low-grade Gliomas: Report of Two Cases and Review of a Rare Pathological Phenomenon.
Avinash KS; Thakar S; Aryan S; Ghosal N; Hegde AS
Neurol India; 2019; 67(4):1100-1106. PubMed ID: 31512645
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.
Stone TJ; Keeley A; Virasami A; Harkness W; Tisdall M; Izquierdo Delgado E; Gutteridge A; Brooks T; Kristiansen M; Chalker J; Wilkhu L; Mifsud W; Apps J; Thom M; Hubank M; Forshew T; Cross JH; Hargrave D; Ham J; Jacques TS
Acta Neuropathol; 2018 Jan; 135(1):115-129. PubMed ID: 29058119
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of H3 K27M-mutant gliomas in adults.
Meyronet D; Esteban-Mader M; Bonnet C; Joly MO; Uro-Coste E; Amiel-Benouaich A; Forest F; Rousselot-Denis C; Burel-Vandenbos F; Bourg V; Guyotat J; Fenouil T; Jouvet A; Honnorat J; Ducray F
Neuro Oncol; 2017 Aug; 19(8):1127-1134. PubMed ID: 28201752
[TBL] [Abstract][Full Text] [Related]
35. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
36. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
37. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
38. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases.
Vizcaino MA; Giannini C; Lalich D; Nael A; Jenkins RB; Tran Q; Orr BA; Abdullaev Z; Aldape K; Vaubel RA
J Neuropathol Exp Neurol; 2024 May; 83(6):416-424. PubMed ID: 38699943
[TBL] [Abstract][Full Text] [Related]
39. [Brain tumors in patients with intractable epilepsy: a clinicopathologic study of 35 cases].
Sun FH; Piao YS; Wang W; Chen L; Wei LF; Yang H; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):153-7. PubMed ID: 19575848
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
